ID: ALA2435918

Max Phase: Preclinical

Molecular Formula: C21H16F6N2

Molecular Weight: 410.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  FC(F)(F)c1cc(CNCc2cnccc2-c2ccccc2)cc(C(F)(F)F)c1

Standard InChI:  InChI=1S/C21H16F6N2/c22-20(23,24)17-8-14(9-18(10-17)21(25,26)27)11-29-13-16-12-28-7-6-19(16)15-4-2-1-3-5-15/h1-10,12,29H,11,13H2

Standard InChI Key:  RDZWUOGMLNAQDK-UHFFFAOYSA-N

Associated Targets(Human)

G-protein coupled bile acid receptor 1 1723 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 410.36Molecular Weight (Monoisotopic): 410.1218AlogP: 6.08#Rotatable Bonds: 5
Polar Surface Area: 24.92Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.10CX LogP: 5.44CX LogD: 4.67
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -0.92

References

1. Zhu J, Ning M, Guo C, Zhang L, Pan G, Leng Y, Shen J..  (2013)  Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold.,  69  [PMID:24007860] [10.1016/j.ejmech.2013.07.050]

Source